Identifying individuals at high risk of melanoma: A simple tool

European Journal of Cancer Prevention

Volumn 19, Issue 5, 2010, Pages 393-400

  Fortes, Cristina ^a   Mastroeni, Simona ^a   Bakos, Lucio ^b   Antonelli, Gianluca ^a   Alessandroni, Livia ^a   Pilla, Maria Antonietta ^a   Alotto, Massimo ^a   Zappalà, Alba ^a   Manoorannparampill, Thomas ^a   Bonamigo, Renan ^c   Pasquini, Paolo ^a   Melchi, Franco ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

prevention tool; risk score melanoma validation; skin cancer

Indexed keywords

ARTICLE; BRAILLE; CANCER RISK; HAIR COLOR; HIGH RISK PATIENT; HUMAN; ITALY; LENTIGO; MELANOMA; NEVUS; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN COLOR; SUNBURN; AREA UNDER THE CURVE; BRAZIL; EVALUATION STUDY; FEMALE; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; STATISTICAL MODEL;

AREA UNDER CURVE; BRAZIL; FEMALE; HUMANS; ITALY; MALE; MELANOMA; META-ANALYSIS AS TOPIC; MIDDLE AGED; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 77955280550     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833b492f     Document Type: Article

References (36)

1. Altman DG, Vergouwe Y, Royston P, Moons KG (2009). Prognosis and prognostic research: validating a prognostic model. BMJ 338:1432-1435.
2. Bakos L, Masiero NC, Bakos RM, Burttet RM, Wagner MB, Benzano D (2009). European ancestry and cutaneous melanoma in Southern Brazil. JEADV 23:304-307.
3. Bernstein EF, Underhill CB, Hahn PJ, Brown DB, Uitto J (1996). Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol 135:255-262.
4. Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F (2004). Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 96:785-795.
5. Cho E, Rosner BA, Feskanich D, Colditz GA (2005). Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 23:2669-2675.
6. Colditz GA, Rosner B (2000). Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses's Health Study. Am J Epidemiol 152:950-964.
7. De Vries E, Coebergh JW (2005). Melanoma incidence has risen in Europe. BMJ 331:698.
8. DeLong ER, DeLong DM, Clarke-Pearson DL (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
9. Dodd AT, Morelli J, Mokrohisky ST, Asdigian N, Byers TE, Crane LA (2007). Melanocytic nevi and sun exposure in a cohort of Colorado children: anatomic distribution and site-specific sunburn. Cancer Epidemiol Biomarkers Prev 16:2136-2143.
10. Downing A, Yu XQ, Newton-Bishop J, Forman D (2008). Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 123:861-866.
11. English DR, Mac Lennan R (1990). Epidemiological studies of melanocytic naevi protocol for identifying and recording naevi. Lyon: International Agency for Research on Cancer. IARC internal report no 90/002.
12. Fears TR, Guerry D VI, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, et al. (2006). Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 24:3590-3596.
13. Fortes C (2002). Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol 31:446-448.
14. Fortes C, de Vries E (2008). Non solar occupational risk factors for cutaneous melanoma. Int J Dermatol 47:319-328.
15. Fortes C, Mastroeni S, Sera F, Concolino F, Abeni D, Melchi F, et al. (2006). Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Institute Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy. Eur J Cancer Prev 15:171-177.
16. Fortes C, Mastroeni S, Melchi F, Pilla MA, Alotto M, Antonelli G, et al. (2007). The association between residential pesticide use and cutaneous melanoma. Eur J Cancer 43:1066-1075.
17. Fortes C, Mastroeni S, Melchi F, Pilla MA, Alotto M, Antonelli G, et al. (2008). A protective effect of the Mediterranean diet for cutaneous melanoma. Int J Epidemiol 37:1018-1029.
18. Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM (2005). Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 97:715-723.
19. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF (2005a). Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28-44. (Pubitemid 40029657)
20. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, Melchi CF (2005b). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45-60. (Pubitemid 40029658)
21. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. (2005c). Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040-2059.
22. Garbe C, Eigentler TK (2007). Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res 17:117-127.
23. Gefeller O, Tarantino J, Lederer P, Uter W, Pfahlberg AB (2007). The relation between patterns of vacation sun exposure and the development of acquired melanocytic nevi in German children 6-7 years of age. Am J Epidemiol 165:1162-1169.
24. Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36.
25. Herd RM, Cooper EJ, Hunter JA, McLaren K, Chetty U, Watson AC, Gollock J (1995). Cutaneous malignant melanoma. Publicity, screening clinics and survival - the Edinburgh experience 1982-1990. Br J Dermatol 132:563-570.
26. High WA, Robinson WA (2007). Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol 23:61-79.
27. König IR, Malley JD, Weimar C, Diener HC, Ziegler A; German Stroke Study Collaboration (2007). Practical experiences on the necessity of external validation. Stat Med 26:5499-5511.
28. Lee EY, Williamson R, Watt P, Hughes MC, Green AC, Whiteman DC (2006). Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer 119: 636-642.
29. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009). Increasing burden of melanoma in the United States. J Invest Dermatol 129:666-674. doi:10.1038/jid.2008.423.
30. MacKie RM, Hole D (1992). Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 304:1012-1015.
31. MacKie RM, McHenry P, Hole D (1993). Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 341:1618-1620.
32. Masri GD, Clark WH Jr, Guerry D VI, Halpern A, Thompson CJ, Elder DE (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22:1042-1048.
33. Moons KG, Royston P, Vergouwe Y, Groobe D, Altman D (2009). Prognosis and prognostic research: what, why, and how? BMJ 338:1317-1320.
34. Rosner BA, Colditz GA, Webb PM, Hankinson SE (2005). Mathematical models of ovarian cancer incidence. Epidemiology 16:508-515.
35. Rossi CR, Vecchiato A, Bezze G, Mastrangelo G, Montesco MC, Mocellin S, et al. (2000). Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res 10:181-187.
36. Spitz MR, Hong WK, Amos CI,Wu X, Schabath MB, Dong Q, et al. (2007). A risk model for prediction of lung cancer. J Natl Cancer Inst 99:715-726.